1. Home
  2. WTO vs VRAX Comparison

WTO vs VRAX Comparison

Compare WTO & VRAX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

WTO

UTime Limited

HOLD

Current Price

$2.87

Market Cap

5.1M

Sector

Technology

ML Signal

HOLD

Logo Virax Biolabs Group Limited

VRAX

Virax Biolabs Group Limited

HOLD

Current Price

$0.19

Market Cap

1.7M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
WTO
VRAX
Founded
2008
2013
Country
China
United Kingdom
Employees
172
N/A
Industry
Consumer Electronics/Appliances
Biotechnology: In Vitro & In Vivo Diagnostic Substances
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
5.1M
1.7M
IPO Year
2019
2021

Fundamental Metrics

Financial Performance
Metric
WTO
VRAX
Price
$2.87
$0.19
Analyst Decision
Strong Buy
Analyst Count
0
1
Target Price
N/A
$1.00
AVG Volume (30 Days)
177.6K
190.7K
Earning Date
01-01-0001
01-01-0001
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
N/A
$217,274.83
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$0.02
$0.19
52 Week High
$4.50
$1.35

Technical Indicators

Market Signals
Indicator
WTO
VRAX
Relative Strength Index (RSI) 60.40 36.07
Support Level $0.78 N/A
Resistance Level $3.77 $0.25
Average True Range (ATR) 0.33 0.02
MACD -0.10 0.00
Stochastic Oscillator 28.03 10.77

Price Performance

Historical Comparison
WTO
VRAX

About WTO UTime Limited

UTime Ltd is engaged in the design, development, production, sales and brand operation of mobile phones, accessories and related consumer electronics. It also provides Electronics Manufacturing Services (EMS), including Original Equipment Manufacturer (OEM) and Original Design Manufacturer (ODM) services, for renowned brands. The company operates in China and its products are sold globally, including Mexico, Brazil, the United States, and other emerging markets in South Asia and Africa as well as Europe. It has two in-house brands, UTime, known as its middle-to-high end label and targets middle class consumers from emerging markets; as its low- to mid-end brand, is positioned to the grassroots consumers and price-sensitive consumers in emerging markets.

About VRAX Virax Biolabs Group Limited

Virax Biolabs Group Ltd is an inventive biotechnology company focused on the detection of immune responses to and diagnosis of viral diseases. Through its ViraxImmune platform and ImmuneSelect portfolio of research-use-only (RUO) products and services, the Company is building an immune-profiling offering that spans RUO assays, preclinical immunology services and, longer term, T cell-based diagnostics aimed at post-acute infection syndromes (PAIS) such as Long COVID and other chronic conditions linked to immune dysregulation.

Share on Social Networks: